መነሻ › የኩላሊት ካንሰር (ሪናል ሴል ካርሲኖማ) › Pennsylvania › Pittsburgh
በPittsburgh፣ PA ለየኩላሊት ካንሰር (ሪናል ሴል ካርሲኖማ) የሚደረጉ ክሊኒካዊ ጥናቶች
ለየኩላሊት ካንሰር (ሪናል ሴል ካርሲኖማ) የሚደረጉ 15 ጥናቶች በPittsburgh እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Research Site, Pittsburgh
A Phase 1 Study of the Safety and Tolerability of CTX-10726
ተሳታዮችን በመፈለግ ላይደረጃ 1
- UPMC Hillman Cancer Center, Pittsburgh
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- UPMC Cancer Center/Hillman Cancer Center ( Site 5017), Pittsburgh
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Exelixis Clinical Site #32, Pittsburgh
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 2
- UPMC Hillman Cancer Center, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- UPMC-Saint Clair Hospital Cancer Center, Pittsburgh
- እና 2 ተጨማሪ
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Allegheny General Hospital, Pittsburgh
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC-Saint Margaret, Pittsburgh
- እና 14 ተጨማሪ
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- UPMC Hillman Cancer Center, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- UPMC-Saint Clair Hospital Cancer Center, Pittsburgh
- እና 3 ተጨማሪ
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site, Pittsburgh
Autologous Dendritic Cell Vaccine in Kidney Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- UPMC Department of Urology, Pittsburgh
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- UPMC Hillman Cancer Center, Pittsburgh
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- UPMC Hillman Cancer Ctr /ID# 225706, Pittsburgh
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
ተሳታዮችን በመፈለግ ላይደረጃ 2
- UPMC Hillman Cancer Center, Pittsburgh
A Study of VET3-TGI in Patients With Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- UPMC- Hillman Cancer Center, Pittsburgh
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
ተሳታዮችን በመፈለግ ላይደረጃ 3
- UPMC-Saint Margaret, Pittsburgh
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
- UPMC-Shadyside Hospital, Pittsburgh
- እና 9 ተጨማሪ
በሌሎች ከተሞች ለየኩላሊት ካንሰር (ሪናል ሴል ካርሲኖማ) የሚደረጉ ጥናቶች
- Houston, TX35 ጥናቶች
- New York City, NY27 ጥናቶች
- Nashville, TN23 ጥናቶች
- Dallas, TX23 ጥናቶች
- St. Louis, MO23 ጥናቶች
- Los Angeles, CA20 ጥናቶች
- Boston, MA16 ጥናቶች
- Baldwin Park, CA16 ጥናቶች
- Philadelphia, PA15 ጥናቶች
- Queens, NY15 ጥናቶች
- Rochester, MN14 ጥናቶች
- Cleveland, OH14 ጥናቶች
በPittsburgh ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር48 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)41 ጥናቶች
- የጡንቻ ካንሰር39 ጥናቶች
- የኮሎሬክታል ካንሰር32 ጥናቶች
- Metastatic Cancer31 ጥናቶች
- ሜላኖማ31 ጥናቶች
- የእንቁላል ካንሰር30 ጥናቶች
- የኤንዶሜትሪየም ካንሰር23 ጥናቶች
- የፕሮስቴት ካንሰር23 ጥናቶች
- የሳንባ ካንሰር23 ጥናቶች
- የራስ እና የአንገት ስኩዋመስ ሴል ካርሲኖማ22 ጥናቶች
- ስትሮክ22 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።